Skip to main content
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease logoLink to Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
. 2019 Oct 31;8(21):e013146. doi: 10.1161/JAHA.119.013146

Association Between Neighborhood Walkability and Predicted 10‐Year Cardiovascular Disease Risk: The CANHEART (Cardiovascular Health in Ambulatory Care Research Team) Cohort

Nicholas A Howell 1,2,3,6,, Jack V Tu 2,4,6,7, Rahim Moineddin 5,6, Anna Chu 3,6, Gillian L Booth 1,2,4,6
PMCID: PMC6898849  PMID: 31665997

Abstract

Background

Individuals living in unwalkable neighborhoods appear to be less physically active and more likely to develop obesity, diabetes mellitus, and hypertension. It is unclear whether neighborhood walkability is a risk factor for future cardiovascular disease.

Methods and Results

We studied residents living in major urban centers in Ontario, Canada on January 1, 2008, using linked electronic medical record and administrative health data from the CANHEART (Cardiovascular Health in Ambulatory Care Research Team) cohort. Walkability was assessed using a validated index based on population and residential density, street connectivity, and the number of walkable destinations in each neighborhood, divided into quintiles (Q). The primary outcome was a predicted 10‐year cardiovascular disease risk of ≥7.5% (recommended threshold for statin use) assessed by the American College of Cardiology/American Heart Association Pooled Cohort Equation. Adjusted associations were estimated using logistic regression models. Secondary outcomes included measured systolic blood pressure, total and high‐density lipoprotein cholesterol levels, prior diabetes mellitus diagnosis, and current smoking status. In total, 44 448 individuals were included in our analyses. Fully adjusted analyses found a nonlinear relationship between walkability and predicted 10‐year cardiovascular disease risk (least [Q1] versus most [Q5] walkable neighborhood: odds ratio =1.09, 95% CI: 0.98, 1.22), with the greatest difference between Q3 and Q5 (odds ratio=1.33, 95% CI: 1.23, 1.45). Dose–response associations were observed for systolic blood pressure, high‐density lipoprotein cholesterol, and diabetes mellitus risk, while an inverse association was observed with smoking status.

Conclusions

In our setting, adults living in less walkable neighborhoods had a higher predicted 10‐year cardiovascular disease risk than those living in highly walkable areas.

Keywords: built environment, cardiovascular disease risk, diabetes mellitus, smoking, walkability

Subject Categories: Epidemiology; Diabetes, Type 2; Lifestyle; Primary Prevention; Risk Factors


Clinical Perspective

What Is New?

  • Adults residing in less walkable neighborhoods had a higher predicted 10‐year risk of cardiovascular disease, a lower high‐density lipoprotein cholesterol level, higher systolic blood pressure, and higher likelihood of having diabetes mellitus, but were also less likely to smoke.

What Are the Clinical Implications?

  • Living in neighborhoods that make it easier to be physically active is associated with reduced risk of cardiovascular disease.

Introduction

Cardiovascular disease remains one of the most common causes of morbidity and mortality globally.1 Regular physical activity is associated with a better cardiometabolic risk profile, including a lower risk of diabetes mellitus, hypertension, and major cardiovascular events.2, 3, 4, 5, 6, 7, 8 The protective relationship between physical activity and cardiovascular risk is likely mediated in large part through effects on body weight and visceral adiposity, leading to improvements in insulin sensitivity and downstream metabolic processes.9, 10, 11, 12, 13 While national guidelines recommend that all adults accumulate a minimum of 150 minutes of moderate to high intensity physical activity each week,14, 15 nearly 1 in 4 American adults do not engage in any form of leisure‐time physical activity.16

Public policies that make it easier to incorporate physical activity into daily life have the potential to increase participation in physical activity on a broad scale. Urban development practices that create a supportive, walkable environment is one such approach. Neighborhood walkability has been positively associated with walking, cycling, and overall physical activity levels, and inversely associated with car use.17, 18, 19, 20 Moreover, residents living in highly walkable neighborhoods appear to have lower rates of overweight and obesity, and less age‐related weight gain over time.18, 19, 20 Recently, several studies have suggested that walkability may also be inversely associated with traditional cardiovascular risk factors including diabetes mellitus, hypertension, and dyslipidemia.21, 22, 23 While each of these risk factors is important on their own, cardiovascular risk factors often co‐occur and may act synergistically to impact one's overall risk of cardiovascular disease outcomes.24, 25, 26 As such, it is important to globally assess the impact of walkability on cardiovascular risk. In a sample of 3593 people, Coffee and colleagues found a small inverse association between walkability and an aggregate outcome including several cardiovascular disease risk factors (hypertension, abdominal adiposity, reduced high‐density lipoprotein [HDL] cholesterol, raised triglycerides, raised low‐density lipoprotein cholesterol, and raised fasting plasma glucose).27 Another study of 5805 individuals by Unger and others identified that individuals who perceived their neighborhood to be more supportive of physical activity were more likely to have ideal cardiovascular health based on various cardiovascular risk factors.28 However, neither study, nor others in the literature have examined the association between walkability and the likelihood of future cardiovascular disease. Understanding the potential for interventions that promote walkability to reduce the burden of cardiovascular disease in the population is a critical step to guide public policies in this area.

The aim of the current study was to test whether residents living in less walkable neighborhoods have a higher predicted 10‐year cardiovascular disease risk compared with those living in highly walkable areas. To do this, we utilized data from a large, population‐based sample drawn from 15 municipalities in Ontario, Canada to evaluate the relationship between neighborhood walkability and predicted 10‐year cardiovascular risk based on calculated American College of Cardiology/American Heart Association (ACC/AHA) Pooled Cohort Equation risk scores. We hypothesized that among community‐dwelling adults free of prior cardiovascular disease, residence in less walkable areas would be associated with a higher predicted 10‐year cardiovascular risk, compared with residence in high walkability neighborhoods.

Methods

Design, Setting, and Population

A cross‐sectional sample was drawn of community‐dwelling individuals residing in 15 major urban centers in Ontario, Canada on January 1, 2008. Individuals were selected for inclusion from a cohort created from linked health administrative databases, known as the CANHEART (Cardiovascular Health in Ambulatory Care Research Team) cohort.29 These data sets were linked using unique encoded identifiers and analyzed at ICES. A full description of each can be found in Data S1. The sample was further restricted to members of the cohort aged 40 to 74 years in whom clinical information from primary care electronic medical records was available. We excluded individuals with prior cardiovascular events (1992–2008), including hospitalization for myocardial infarction, stroke, congestive heart failure, percutaneous coronary intervention, or coronary artery bypass graft surgery. Individuals residing in a long‐term care facility within the previous 5 years and individuals who were not residents in Ontario for the entire 2‐year period preceding baseline (2006–2007) were also excluded. This study was approved by the Sunnybrook Health Sciences and University of Toronto Research Ethics Boards. No informed consent was required. The data set from this study is held securely in encoded form at ICES.30 While data‐sharing agreements prohibit ICES from making the data set publicly available, access may be granted to those who meet prespecified criteria for confidential access, available at www.ices.on.ca/DAS. The full data set creation plan and underlying analytic code are available from the authors upon request, with the understanding that the programs may rely upon coding templates or macros that are unique to ICES.

Walkability

Individuals were assigned a walkability exposure based on their dissemination area of residence, a small unit of geography that corresponds to approximately several city blocks in major urban centers. Residential walkability was assessed using a validated index developed for Ontario cities, which predicts transportation patterns (walking, cycling, public transit use, car use) and car ownership.18, 19 It consists of 4 equally weighted components: (1) population density, (2) dwelling density, (3) street connectivity, and (4) number of accessible destinations (eg, banks, grocery stores, restaurants) (Data S1). The components were derived based on geographic boundaries that represent the approximate distance one could travel within 10 minutes from the center of each dissemination area (800 m). Each of these components is individually standardized before being totaled to create the final score. For analysis, walkability scores are treated as quintiles (Q1 lowest, Q5 highest) using cut points derived from neighborhoods (dissemination areas) across the entire study area. As such, the number of individuals across quintiles is not equally divided.

Outcomes

The primary outcome in this study was predicted 10‐year cardiovascular disease risk measured using ACC/AHA Pooled Cohort Equation risk score.31 These scores were designed to predict hard atherosclerotic cardiovascular disease end points (nonfatal myocardial infarction, coronary heart disease death, nonfatal and fatal stroke). Scores were generated using sex‐stratified models based on age, HDL and total cholesterol, systolic blood pressure (treated or untreated), smoking status, and diabetes mellitus diagnosis. For our main analyses, we dichotomized the predicted 10‐year risk derived from the ACC/AHA score at a threshold of 7.5%, which is the threshold used by the ACC/AHA for recommending statin therapy.32 As a sensitivity analysis, we also used a higher threshold of ≥10%, corresponding to current guidelines by the United States Preventive Services Task Force for use of statins and aspirin among individuals 50 to 59 years of age.33, 34 As secondary outcomes, we further assessed relationships between walkability and the subcomponents of the ACC/AHA score: diagnosis of diabetes mellitus, systolic blood pressure, total cholesterol, HDL cholesterol, and smoking status. Diabetes mellitus status was identified using a validated algorithm with sensitivity and specificity values of 0.87 and 0.97.35, 36 Systolic blood pressures were taken from the Electronic Medical Record Administrative data Linked Database (EMRALD). The closest measurement preceding the baseline date (within 2 years) was used, or within 5 years after the baseline date if no earlier value was available. The closest cholesterol measurement recorded either in EMRALD or a commercial laboratory (Dynacare Medical Laboratories) database was used, with the same criteria regarding proximity of the value to the baseline as used for blood pressure. Current smoking status was ascertained using the EMRALD data.

Covariates

Information on other baseline sociodemographic and clinical confounders were assessed. These included age, sex, ethnicity, immigration history, neighborhood median household income, use of antihypertensive medications, use of statin medications, chronic obstructive pulmonary disease diagnosis, and number of comorbidities assessed using Johns Hopkins Collapsed Aggregated Diagnostic Groups (Johns Hopkins ACG® System Ver. 7.0). Collapsed Aggregated Diagnostic Groups representing pregnancy‐related care and preventive care were not included in the counts. Neighborhood income quintile data were derived from the 2006 Canadian Census based on the household income per single person equivalent within the dissemination area (neighborhood) across the general population. Full details are included in Table S1.

Analysis

Descriptive statistics were tabulated by walkability quintile (mean [SD] for continuous variables, percentage for dichotomous/nominal variables). Continuous outcomes were modeled using multiple linear regression with the generalized estimating equations method to account for clustering at the dissemination area level. Binary outcomes were modeled using logistic regression, also estimating cluster‐robust standard errors with generalized estimating equations. Influence diagnostics (DFBetas) were checked to assess estimates’ sensitivity to the inclusion of individual observations. Covariates included in the model for cardiovascular risk were sex, ethnicity, immigration history, neighborhood income, and number of comorbidities. Covariates for models of diabetes mellitus, systolic blood pressure, HDL, and total cholesterol included the above as well as age, smoking status, and chronic obstructive pulmonary disease. Models for HDL and total cholesterol additionally included whether the individual was prescribed a statin, and models for blood pressure similarly included a variable for the use of antihypertensive medications. Smoking models contained the same sociodemographic variables as for the cholesterol models. However, since smoking may plausibly influence a wide variety of comorbidities, the only collapsed aggregated diagnostic group variables included were markers for use of preventive care and psychosocial comorbidity. To account for missing data, multiple imputation using chained equations was performed using 5 imputation sets (Data S1). Several sensitivity analyses were performed to assess the robustness of the results to modeling assumptions. We assessed the sensitivity of the results to the use of multiple imputation by presenting results derived from complete case analyses. Additionally, as a post hoc assessment of how smoking may affect associations between neighborhood walkability and predicted 10‐year cardiovascular disease risk, we performed analyses stratified by current smoking status. All analyses were performed using SAS Enterprise version 7.1 (SAS Institute, Cary, NC).

Results

Descriptive Analyses

Overall, 44 448 individuals were included in the sample. The sociodemographic profile of individuals living in high versus low walkability neighborhoods were similar for many attributes, with the exception of neighborhood income (Table 1). Whereas only 6.4% of individuals in the least walkable neighborhoods were in the lowest neighborhood income quintile, >20% were in the lowest neighborhood income quintile in the most walkable neighborhoods. The distribution of comorbidities overall was also similar, but individuals living in highly walkable areas were more likely to have a prior diagnosis of chronic obstructive pulmonary disease.

Table 1.

Sample Characteristics by Walkability Quintiles

Characteristic Walkability Quintiles (Q)
Q1 (Lowest) N=5375 Q2 N=5544 Q3 N=5491 Q4 N=8091 Q5 (Highest) N=19 947
Mean age, y (SD) 53.3 (9.1) 53.8 (9.1) 54.0 (9.3) 53.5 (9.2) 52.9 (9.0)
Female (%) 3065 (57.0) 3215 (58.0) 3147 (57.3) 4826 (59.6) 11 254 (56.4)
Ethnicity
Chinese (%) 171 (3.2) 185 (3.3) 197 (3.6) 263 (3.3) 554 (2.8)
South Asian (%) 99 (1.8) 70 (1.3) 94 (1.7) 108 (1.3) 231 (1.2)
Other (%) 5105 (95.0) 5289 (95.4) 5200 (94.7) 7720 (95.4) 19 162 (96.1)
Immigration history (%)
0–5 y 71 (1.3) 85 (1.5) 87 (1.6) 169 (2.1) 387 (1.9)
5–10 y 96 (1.8) 112 (2.0) 134 (2.4) 173 (2.1) 352 (1.8)
Long‐term resident 5208 (96.9) 5347 (96.4) 5270 (96.0) 7749 (95.8) 19 208 (96.3)
Neighborhood income quintile (%)
Q1 (low) 343 (6.4) 699 (12.6) 896 (16.3) 1629 (20.2) 4153 (20.9)
Q2 428 (8.0) 747 (13.5) 1107 (20.2) 1501 (18.6) 3342 (16.8)
Q3 860 (16.1) 988 (17.8) 1036 (18.9) 1029 (12.8) 3406 (17.2)
Q4 1332 (25.0) 1329 (24.0) 1139 (20.7) 1146 (14.2) 3212 (16.2)
Q5 (high) 2369 (44.4) 1779 (32.1) 1313 (23.9) 2746 (34.1) 5723 (28.9)
COPD (%) 285 (5.3) 334 (6.0) 375 (6.8) 560 (6.9) 1635 (8.2)
Median number of comorbidities (IQR) 3 (2–5) 3 (2–5) 3 (2–5) 3 (2–5) 3 (2–5)

All values are frequencies unless otherwise stated. All values are rounded to the nearest significant digit. Imputed data were not used in calculation of descriptive statistics. COPD indicates chronic obstructive pulmonary disease; IQR, interquartile range.

Association Between Neighborhood Walkability and Cardiovascular Disease Risk

The results of regression modeling for ACC/AHA Pooled Cohort Equation risk scores are presented in Table 2. Compared with individuals living in the most walkable neighborhoods (Q5), residents in less walkable areas were 9% to 33% more likely to have a high predicted 10‐year cardiovascular risk based on an ACC/AHA score of 7.5% or greater, after adjustment for sociodemographic confounders and comorbidities (Model 3). However, the pattern was nonlinear, with individuals in the third quintile of walkability exposure (Q3) having the greatest increase in predicted risk relative to Q5 and those in the lowest quintile (Q1) the least and with CIs crossing 1.0. Sensitivity analyses showed consistent results, with the likelihood of having a predicted cardiovascular risk of 10% or greater significantly higher in all 4 lower quintiles of walkability (Q1–Q4) relative to Q5 (Table 2).

Table 2.

Association Between Neighborhood Walkability and 10‐Year Cardiovascular Disease Risk ≥7.5% and 10%

Variable/Outcome Model 1 OR (95% CI) Model 2 OR (95% CI) Model 3 OR (95% CI)
ACC/AHA ≥7.5%
Walkability
Q1 (low) 1.04 (0.93, 1.16) 1.08 (0.97, 1.21) 1.09 (0.98, 1.22)
Q2 1.21 (1.11, 1.32) 1.25 (1.15, 1.37) 1.26 (1.15, 1.38)
Q3 1.29 (1.19, 1.41) 1.32 (1.21, 1.44) 1.33 (1.23, 1.45)
Q4 1.19 (1.10, 1.28) 1.20 (1.11, 1.29) 1.22 (1.13, 1.31)
Q5 (high) Ref Ref Ref
ACC/AHA ≥10.0%
Walkability
Q1 (low) 1.07 (0.96, 1.18) 1.12 (1.01, 1.24) 1.13 (1.02, 1.26)
Q2 1.21 (1.10, 1.33) 1.26 (1.14, 1.38) 1.26 (1.15, 1.39)
Q3 1.31 (1.20, 1.44) 1.34 (1.22, 1.47) 1.36 (1.24, 1.49)
Q4 1.20 (1.10, 1.30) 1.20 (1.10, 1.31) 1.23 (1.13, 1.34)
Q5 (high) Ref Ref Ref

Model 1 associations are adjusted for sex only (n.b., age is a component of ACC/AHA Pooled Cohort Equation risk score). Model 2 associations adjusted for model 1 covariates and ethnicity, immigration history, and neighborhood income. Model 3 associations adjusted for model 2 covariates and number of comorbidities. ACC/AHA indicates American College of Cardiology/American Heart Association; OR, odds ratio; Q, quintile; Ref, reference category.

Association Between Neighborhood Walkability and Traditional Cardiovascular Disease Risk Factors

Figure 1 shows the association between walkability and several individual components of the ACC/AHA Pooled Cohort Equation. After adjustment for sociodemographic covariates, comorbidities, smoking, and medication use, individuals living in the least versus most walkable neighborhoods were found to have significantly higher mean systolic blood pressure (Figure 1A: Q1 versus Q5=2.54 mm Hg, 95% CI: 1.90, 3.19) and lower mean HDL cholesterol (Figure 1B: Q5 versus Q1 −1.67 mg/dL, 95% CI: −2.34, −1.01). Total cholesterol levels did not differ significantly between groups (Figure 1C). Individuals living in the least walkable areas also had a significantly higher adjusted odds of having a prior diagnosis of diabetes mellitus (Figure 2A: Q5 versus Q1 odds ratio=1.22, 95% CI: 1.08, 1.37). For each of these risk factors, the relationship appeared to be dose dependent. Conversely, living in a less walkable neighborhood was associated with a lower likelihood of smoking (Figure 2B: Q1 versus Q5 odds ratio=0.75, 95% CI: 0.67, 0.84).

Figure 1.

Figure 1

Association between neighborhood walkability, systolic blood pressure, high‐density lipoprotein cholesterol, and total cholesterol. Significant associations were identified between walkability and SBP (A) and HDL cholesterol (B). No statistically significant association was identified between walkability and total cholesterol (C). All values were adjusted for age, sex, ethnicity, immigration history, and neighborhood income. Covariates for models of SBP, HDL, and total cholesterol included the above as well as smoking status, COPD, and number of comorbidities. Models for HDL and total cholesterol additionally included whether the individual was prescribed a statin, and models for blood pressure similarly included a variable for the use of antihypertensive medications. COPD indicates chronic obstructive pulmonary disease; HDL, high‐density lipoprotein; SBP, systolic blood pressure. Q1 to Q5: Walkability Quintiles (Q1: Low, Q5: High).

Figure 2.

Figure 2

Association between neighborhood walkability, diabetes mellitus, and smoking. Significant associations were identified between walkability and odds of diabetes mellitus (A) diagnosis and smoking status (B). All values were adjusted for age, sex, ethnicity, immigration history, and neighborhood income. Covariates for the model of diabetes mellitus included the above as well as smoking status, COPD, and number of comorbidities. The model for smoking contained the same sociodemographic variables as for the diabetes mellitus models. However, since smoking may plausibly influence a wide variety of comorbidities, only use of preventive care and psychosocial comorbidity were included and not total number of comorbidities or COPD specifically. COPD, indicates chronic obstructive pulmonary disease; Q1 to Q5: Walkability Quintiles (Q1: Low, Q5: High).

Sensitivity Analyses

To explore the role of smoking in the nonlinear relationship between walkability and predicted 10‐year cardiovascular risk, we performed analyses stratified by smoking status (Table S2). While associations were strengthened among nonsmokers and were generally attenuated among smokers, a nonlinear pattern of association was still present. Models from complete case analyses revealed results comparable to those from multiple imputation models (Table S3).

Discussion

In our sample of 44 448 community‐dwelling individuals in Southern Ontario, we found that low neighborhood walkability was associated with a higher predicted 10‐year risk of having a cardiovascular disease event. Furthermore, we observed that decreasing walkability follows a dose–response relationship with increasing systolic blood pressure, HDL cholesterol, and likelihood of diabetes mellitus, but conversely, that lower walkability is associated with a lower likelihood of smoking. These results support connections between walkability and overall cardiovascular risk and further highlight its potential as an upstream correlate of many cardiovascular risk factors. However, our findings also suggest that the differences in predicted cardiovascular risk may be partially offset because of higher levels of smoking in highly walkable versus less walkable neighborhoods.

To our knowledge, our results are the first to report that residing in a less walkable neighborhood is associated with a clinically significant elevation in predicted 10‐year risk of cardiovascular disease. These findings are broadly consistent with recent research identifying inverse associations between walkability and individual risk factors and positive associations with population‐based indicators of cardiovascular health.19, 20, 21, 28, 37, 38, 39 Recent work by Unger and colleagues found a 20% increase in the odds of having ideal versus poor cardiovascular health for each 1 SD improvement in individuals’ “walking/physical activity environment,” as assessed using the AHA 2020 Strategic Impact Goals framework.28 Coffee et al also found that the rates of developing a cardiovascular risk factor decreased 6% for each 10‐unit increase in walkability (≈1.5 SD).27 The magnitude of association is also comparable with those observed contrasting the most versus least walkable neighborhoods and diabetes mellitus and hypertension in other studies.19, 40, 41 Conversely, Braun et al did not report any cross‐sectional or longitudinal association between Walk Score® and metabolic syndrome among participants in the MESA (Multi‐Ethnic Study of Atherosclerosis) cohort.42 As an upstream determinant of health, walkability is believed to affect cardiovascular disease risk by modifying individuals’ participation in physical activity, in particular utilitarian, transportation‐related activity such as walking to work or for the purpose of performing errands. Many studies, including an international study drawing participants from 10 countries, have identified that walkability‐related variables are associated with increased levels of walking and moderate‐to‐vigorous physical activity.19, 20, 43, 44, 45 These increased activity levels may in turn reduce body mass index or slow age‐related weight gain, which can have consequences on the metabolic derangements (eg, insulin resistance) that drive cardiovascular risk.19, 46, 47

Unexpectedly, we found that the association between walkability and 10‐year predicted cardiovascular disease risk may be nonlinear, with the strongest point estimates observed comparing Q3 to Q5 (most walkable neighborhoods), with a weaker difference observed between Q1 (least walkable) versus Q5 exposures. These patterns were not observed for associations between walkability and the secondary outcomes. We identified different patterns in association between walkability and smoking behavior versus walkability and other cardiovascular risk factors, whereby exposure to a less walkable neighborhood was associated with a lower likelihood of being a smoker. This difference likely contributed towards the observed nonlinearity in association between walkability and overall cardiovascular disease risk. However, the nonlinearity in the primary outcome persisted in analyses stratified by individuals’ smoking status. It is not immediately clear what may be causing these patterns of point‐estimates. It is possible that an unaccounted for compositional (ie individual‐level) or contextual (ie neighborhood‐level) variable may be driving this pattern. One possibility in this regard may be that the most suburban areas, farther from the urban core are closer to rural areas or outdoor recreation areas that may be independent drivers of physical activity, while intermediate areas may not benefit from either highly dense, walkable areas or more peri‐urban greenspace. However, in a previous study we have performed within this study area, we did not identify any nonlinear difference in distance to the nearest major park across levels of walkability.19 Another possibility is that with recent demographic shifts that have seen urban areas increasingly occupied by wealthier individuals, marginalized individuals have been displaced towards the inner suburbs. In our previous work we found limited evidence for this possibility.19 The proportion of residents 20 years and older with only a high school education or less appeared to peak in Q3 walkability, paralleling the results we see here, but other markers of socioeconomic status (unemployment rate, poverty rate, proportion of residences in need of major repair) had a more linear trend and indicated that Q5 was most disadvantaged. It is also important to note that the CIs largely overlap across contrasts, so some caution should be used when interpreting the potential nonlinearity of association. Further studies are needed to assess the robustness of this observation and to more deeply explore possible explanations, if replicated.

Our results suggest that neighborhood walkability is associated with clinically relevant differences in predicted cardiovascular disease. This lends support to the idea that neighborhood walkability may serve as an important point for public health intervention to offset risk for atherosclerotic cardiovascular disease. As neighborhoods are created or redeveloped, encouraging cities to permit higher densities and re‐think approaches to zoning to allow mixed‐used developments combining places to work, live, and engage in recreation may provide benefits to public health for existing and future populations. Doing so would reverse the decades‐long trend towards low‐density, suburban developments that predominated the latter half of the 20th century. Additionally, enhancing access to public transportation could enable those living in suburban areas to become more physically active by connecting them with more walkable urban areas and reducing dependence on cars.

Our study also demonstrated a novel association between walkability and smoking rates, emphasizing the importance of taking a broader perspective in understanding neighborhood effects on health. Moreover, for upstream policy interventions to have a clinically meaningful impact, they need to consider all aspects of cardiovascular risk. We observed that highly walkable areas have higher rates of smoking, for reasons that are not entirely clear. It is possible that greater proximity to retail in highly walkable neighborhoods results in more tobacco sellers. This may result in unexpected support for smoking. Previous studies have found that greater distances between home and a tobacco outlet (eg convenience stores) are associated with a higher likelihood of quitting smoking.48, 49 In our study area, highly walkable neighborhoods also had higher levels of poverty, which may have contributed to higher levels of smoking in these areas. While our results persisted after adjustment for sociodemographic characteristics, further adjustment for individual socioeconomic status variables would enhance confidence in this finding. These results may suggest that to reap the full benefit of walkable environments, efforts must be made to curb tobacco availability or target smoking cessation campaigns within areas of higher tobacco availability. However, further studies designed to focus on this question are needed.

Several major strengths of this study are its use of a large population‐based sample, representation from several distinct urban regions, and focus on a clinically meaningful outcome designed to predict hard atherosclerotic cardiovascular disease and guide use of statin medication.31, 32, 33, 34 However, there are some important limitations to the current findings that should be highlighted. Our analyses were cross‐sectional, and so we cannot establish a temporal relationship between walkability and cardiovascular risk. Confounding by neighborhood self‐selection is also possible and could lead to systematic differences in healthy behaviors between populations. Nevertheless, previous studies generally noted that associations between the built environment, risk factors, and health behaviors remain after addressing residential self‐selection, by design or adjustment for neighborhood preference.39, 44, 50 Furthermore, in ours and other samples, walkability is often inversely associated with measures of individual and area‐level socioeconomic status, suggesting that residual confounding may be biasing results to the null.51, 52 Finally, while we did not measure physical activity in the sample as a mediator, previous work in our study area has found that walkability is directly associated with transportation‐related physical activity.19, 20, 43

In sum, we found that individuals living in less walkable neighborhoods have a higher predicted risk of cardiovascular disease events. Future research is needed to confirm these findings using longitudinal designs, and to understand the underlying causes of the association between walkability and smoking. Our findings emphasize the importance of considering the health implications of urban design changes holistically. In particular, strategies to help curb smoking rates in highly walkable areas may help improve the public health impact of urban design improvements.

Sources of Funding

Dr Howell is supported by a Vanier Canada Graduate Scholarship from the Canadian Institutes for Health Research, a CIHR MD/PhD Studentship, a McLaughlin Centre MD/PhD Studentship, and a McLaughlin Centre Graduate Student Award. Dr Tu was supported by a Canada Research Chair in Health Services Research and an Eaton Scholar award from the Department of Medicine at the University of Toronto during the period of this research. Dr Booth is supported by a Clinician‐Scientist Merit Award from the Department of Medicine at the University of Toronto. This study was funded by a Foundation Grant from CIHR (Dr Booth), and an Institute for Circulatory and Respiratory Health/CIHR Team Grant to the CArdiovascular HEalth in Ambulatory Care Research Team (CANHEART). This study was supported by ICES, which is funded by an annual grant from the Ontario MOHLTC. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred.

Disclosures

None.

Supporting information

Data S1. Notes: ACG: Adjusted Clinical Groups; CENSUS: Ontario Canadian Census Profiles; COPD: Ontario Chronic Obstructive Pulmonary Disease Database; DAD: Discharge Abstract Database; EMRALD: Electronic Medical Record Administrative Data Linked Database; ETHNIC: Surname‐Based Ethnicity Group Database; IRCC: Immigration, Refugees and Citizenship Canada Permanent Resident Database; JHACG: Johns Hopkins Adjusted Clinical Groups; OHIP: Ontario Health Insurance Plan Billings Database; RPDB: Registered Persons Database.

Table S1. Description of Covariates Used in Multivariable Models

Table S2. Association Between Neighborhood Walkability and 10‐Year Cardiovascular Disease Risk Stratified by Current Smoking Status

Table S3. Model Results From Complete Case Analyses

Acknowledgments

Parts of this material are based on data and information compiled and provided by the Canadian Institutes for Health Information (CIHI) and the Ontario Ministry of Health and Long‐Term Care (MOHLTC). However, the analyses, conclusions, opinions and statements expressed in this manuscript are those of the authors and not necessarily those of CIHI or MOHLTC. Data on immigration history were obtained from Immigration, Refugees and Citizenship Canada Permanent Resident database. The opinions of the authors here do not necessarily reflect those of Immigration, Refugees and Citizenship Canada. We thank IMS Brogan Inc. for use of their Drug Information Database and Dynacare Medical Laboratories for the use of their laboratory data as part of the CANHEART initiative. Additional Information: Coauthor Jack V. Tu, MD, PhD, MSc, died during the preparation of this manuscript.

(J Am Heart Assoc. 2019;8:e013146 DOI: 10.1161/JAHA.119.013146.)

References

  • 1. Global Burden of Disease 2015 Mortality and Causes of Death Collaborators . Global, regional, and national life expectancy, all‐cause mortality, and cause‐specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459–1544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Wahid A, Manek N, Nichols M, Kelly P, Foster C, Webster P, Kaur A, Friedemann Smith C, Wilkins E, Rayner M, Roberts N, Scarborough P. Quantifying the association between physical activity and cardiovascular disease and diabetes: a systematic review and meta‐analysis. J Am Heart Assoc. 2016;5:e002495 DOI: 10.1161/JAHA.115.002495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Kyu HH, Bachman VF, Alexander LT, Mumford JE, Afshin A, Estep K, Veerman JL, Delwiche K, Iannarone ML, Moyer ML, Cercy K, Vos T, Murray CJL, Forouzanfar MH. Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose‐response meta‐analysis for the Global Burden of Disease Study 2013. BMJ. 2016;354:i3857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Cornelissen VA, Smart NA. Exercise training for blood pressure: a systematic review and meta‐analysis. J Am Heart Assoc. 2013;2:e004473 DOI: 10.1161/JAHA.112.004473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Murtagh EM, Nichols L, Mohammed MA, Holder R, Nevill AM, Murphy MH. The effect of walking on risk factors for cardiovascular disease: an updated systematic review and meta‐analysis of randomised control trials. Prev Med (Baltim). 2015;72:34–43. [DOI] [PubMed] [Google Scholar]
  • 6. Hakim AA, Curb JD, Petrovitch H, Rodriguez BL, Yano K, Ross GW, White LR, Abbott RD. Effects of walking on coronary heart disease in elderly men: the Honolulu Heart Program. Circulation. 1999;100:9–13. [DOI] [PubMed] [Google Scholar]
  • 7. Lear SA, Hu W, Rangarajan S, Gasevic D, Leong D, Iqbal R, Casanova A, Swaminathan S, Anjana RM, Kumar R, Rosengren A, Wei L, Yang W, Chuangshi W, Huaxing L, Nair S, Diaz R, Swidon H, Gupta R, Mohammadifard N, Lopez‐Jaramillo P, Oguz A, Zatonska K, Seron P, Avezum A, Poirier P, Teo K, Yusuf S. The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high‐income, middle‐income, and low‐income countries: the PURE study. Lancet. 2017;390:2643–2654. [DOI] [PubMed] [Google Scholar]
  • 8. Tanasescu M, Leitzmann MF, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Exercise type and intensity in relation to coronary heart disease in men. JAMA. 2002;288:1994–2000. [DOI] [PubMed] [Google Scholar]
  • 9. Verheggen RJHM, Maessen MFH, Green DJ, Hermus ARMM, Hopman MTE, Thijssen DHT. A systematic review and meta‐analysis on the effects of exercise training versus hypocaloric diet: distinct effects on body weight and visceral adipose tissue. Obes Rev. 2016;17:664–690. [DOI] [PubMed] [Google Scholar]
  • 10. Shaw K, Gennat H, O'Rourke P, Del Mar C. Exercise for overweight or obesity. Cochrane Database Syst Rev. 2006;1–112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Diabetes Prevention Program Research Group . Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Heymsfield SB, Wadden TA. Mechanisms, pathophysiology, and management of obesity. N Engl J Med. 2017;376:254–266. [DOI] [PubMed] [Google Scholar]
  • 13. The Look AHEAD Research Group . Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369:145–154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. United States Department of Health and Human Services . Physical Activity Guidelines for Americans. 2nd ed Washington, DC: U.S. Department of Health and Human Services; 2018. [Google Scholar]
  • 15. Anderson TJ, Gregoire J, Hegele RA, Couture P, Mancini GBJ, McPherson R, Francis GA, Poirier P, Lau DC, Grover S, Genest J Jr, Carpentier AC, Dufour R, Gupta M, Ward R, Leiter LA, Lonn E, Ng DS, Pearson GJ, Yates GM, Stone JA, Ur E. 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol. 2013;29:151–167. [DOI] [PubMed] [Google Scholar]
  • 16. Centers for Disease Control and Prevention . National Center for Chronic Disease Prevention and Health Promotion, Division of Nutrition, Physical Activity, and Obesity. Data, Trend and Maps [Internet]. Published: September 27, 2018. Available at: https://www.cdc.gov/nccdphp/dnpao/data-trends-maps/index.html. Accessed October 29, 2018.
  • 17. Hajna S, Ross NA, Brazeau A‐S, Bélisle P, Joseph L, Dasgupta K. Associations between neighbourhood walkability and daily steps in adults: a systematic review and meta‐analysis. BMC Public Health. 2015;15:768 Available at: http://www.biomedcentral.com/1471-2458/15/768. Accessed October 15, 2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Glazier RH, Creatore MI, Weyman JT, Fazli G, Matheson FI, Gozdyra P, Moineddin R, Shriqui VK, Booth GL. Density, destinations or both? A comparison of measures of walkability in relation to transportation behaviors, obesity and diabetes in Toronto, Canada. PLoS One. 2014;9:e85295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Creatore MI, Glazier RH, Moineddin R, Fazli G, Johns A, Gozdyra P, Matheson FI, Kaufman‐Shriqui V, Rosella LC, Manuel DG, Booth GL. Association of neighborhood walkability with change in overweight, obesity, and diabetes. JAMA. 2016;315:2211–2220. [DOI] [PubMed] [Google Scholar]
  • 20. Frank LD, Saelens BE, Powell KE, Chapman JE. Stepping towards causation: do built environments or neighborhood and travel preferences explain physical activity, driving, and obesity? Soc Sci Med. 2007;65:1898–1914. [DOI] [PubMed] [Google Scholar]
  • 21. Chiu M, Rezai M‐R, Maclagan LC, Austin PC, Shah BR, Redelmeier DA, Tu JV. Moving to a highly walkable neighborhood and incidence of hypertension: a propensity‐score matched cohort study. Environ Health Perspect. 2015;124:754–760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Mujahid MS, Diez Roux AV, Morenoff JD, Raghunathan TE, Cooper RS, Ni H, Shea S. Neighborhood characteristics and hypertension. Epidemiology. 2008;19:590–598. [DOI] [PubMed] [Google Scholar]
  • 23. Braun LM, Rodriguez DA, Song Y, Meyer KA, Lewis CE, Reis JP, Gordon‐Larsen P. Changes in walking, body mass index, and cardiometabolic risk factors following residential relocation: longitudinal results from the CARDIA study. J Transp Health. 2016;3:426–439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, Garside DB, Wilson PW. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA. 2003;290:891–897. [DOI] [PubMed] [Google Scholar]
  • 25. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballantyne CM, Heiss G. The metabolic syndrome and 11‐year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities study. Diabetes Care. 2005;28:385–390. [DOI] [PubMed] [Google Scholar]
  • 26. Jackson R, Lawes CMM, Bennett DA, Milne RJ, Rodgers A. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet. 2005;365:434–441. [DOI] [PubMed] [Google Scholar]
  • 27. Coffee NT, Howard N, Paquet C, Hugo G, Daniel M. Is walkability associated with a lower cardiometabolic risk? Health Place. 2013;21:163–169. [DOI] [PubMed] [Google Scholar]
  • 28. Unger E, Diez‐Roux AV, Lloyd‐Jones DM, Mujahid MS, Nettleton JA, Bertoni A, Badon SE, Ning H, Allen NB. Association of neighborhood characteristics with cardiovascular health in the Multi‐Ethnic Study of Atherosclerosis. Circ Cardiovasc Qual Outcomes. 2014;7:524–531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Tu JV, Chu A, Donovan LR, Ko DT, Booth GL, Tu K, Maclagan LC, Guo H, Austin PC, Hogg W, Kapral MK, Wijeysundera HC, Atzema CL, Gershon AS, Alter DA, Lee DS, Jackevicius CA, Bhatia RS, Udell JA, Rezai MR, Stukel TA. The Cardiovascular Health in Ambulatory Care Research Team (CANHEART): using big data to measure and improve cardiovascular health and healthcare services. Circ Cardiovasc Qual Outcomes. 2015;8:204–212. [DOI] [PubMed] [Google Scholar]
  • 30.No Author. ICES Homepage [Internet]. ICES. No publication date. Available at: https://www.ices.on.ca. Accessed August 18, 2019.
  • 31. Goff DC, Lloyd‐Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC, Sorlie P, Stone NJ, Wilson PWF. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S49–S73. [DOI] [PubMed] [Google Scholar]
  • 32. Stone NJ, Robinson J, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd‐Jones DM, McBride P, Schwartz JS, Shero ST, Smith SCJ, Watson K, Wilson PWF. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;129:S1–S45. [DOI] [PubMed] [Google Scholar]
  • 33. Bibbins‐Domingo K. Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. Preventive Services Task Force Recommendations Statement. Ann Intern Med. 2016;164:836–845. [DOI] [PubMed] [Google Scholar]
  • 34. United States Preventive Services Task Force . Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2016;316:1997–2007. [DOI] [PubMed] [Google Scholar]
  • 35. Hux JE, Ivis F, Flintoft V, Bica A. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care. 2002;25:512–516. [DOI] [PubMed] [Google Scholar]
  • 36. Tu K, Chen Z, Lipscombe LL; Taskforce CHEPOR . Prevalence and incidence of hypertension from 1995 to 2005: a population‐based study. CMAJ. 2008;178:1429–1435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Booth GL, Creatore MI, Moineddin R, Gozdyra P, Weyman JT, Matheson FI, Glazier RH. Unwalkable neighborhoods, poverty, and the risk of diabetes among recent immigrants to Canada compared with long‐term residents. Diabetes Care. 2013;36:302–308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Loo CKJ, Greiver M, Aliarzadeh B, Lewis D. Association between neighbourhood walkability and metabolic risk factor influenced by physical activity: a cross‐sectional study of adults in Toronto, Canada. BMJ Open. 2017;7:e013889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Hirsch JA, Diez Roux AV, Moore KA, Evenson KR, Rodriguez DA. Change in walking and body mass index following residential relocation: the Multi‐Ethnic Study of Atherosclerosis. Am J Public Health. 2014;104:e49–e56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Howell NA, Tu JV, Moineddin R, Chen H, Chu A, Hystad P, Booth GL. Interaction between neighborhood walkability and traffic‐related air pollution on hypertension and diabetes: the CANHEART cohort. Environ Int. 2019;132:104799. [DOI] [PubMed] [Google Scholar]
  • 41. Booth GL, Creatore MI, Luo J, Fazli GS, Johns A, Rosella LC, Glazier RH, Moineddin R, Gozdyra P, Austin PC. Neighbourhood walkability and the incidence of diabetes: an inverse probability of treatment weighting analysis. J Epidemiol Community Health. 2019;73:287–294. [DOI] [PubMed] [Google Scholar]
  • 42. Braun LM, Rodriguez DA, Evenson KR, Hirsch JA, Moore KA, Diez Roux AV. Walkability and cardiometabolic risk factors: cross‐sectional and longitudinal associations from the Multi‐Ethnic Study of Atherosclerosis. Health Place. 2016;39:9–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Sallis JF, Cerin E, Conway TL, Adams MA, Frank LD, Pratt M, Salvo D, Schipperijn J, Smith G, Cain KL, Davey R, Kerr J, Lai P‐C, Mitáš J, Reis R, Sarmiento OL, Schofield G, Troelsen J, Van Dyck D, De Bourdeaudhuij I, Owen N. Physical activity in relation to urban environments in 14 cities worldwide: a cross‐sectional study. Lancet. 2016;387:2207–2217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Howell NA, Farber S, Widener MJ, Booth GL. Residential or activity space walkability: what drives transportation physical activity? J Transp Health. 2017;7:160–171. [Google Scholar]
  • 45. Thielman J, Manson H, Chiu M, Copes R, Rosella LC. Residents of highly walkable neighbourhoods in Canadian urban areas do substantially more physical activity: a cross‐sectional analysis. CMAJ Open. 2016;4:E720–E728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Wasfi RA, Dasgupta K, Orpana H, Ross NA. Neighborhood walkability and body mass index trajectories: longitudinal study of Canadians. Am J Public Health. 2016;106:934–940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Auchincloss AH, Diez Roux AV, Brown DG, Erdmann CA, Bertoni AG. Neighborhood resources for physical activity and healthy foods and their association with insulin resistance. Epidemiology. 2008;19:146–157. [DOI] [PubMed] [Google Scholar]
  • 48. Pulakka A, Halonen JI, Kawachi I, Pentti J, Stenholm S, Jokela M, Kaate I, Koskenvuo M, Vahtera J, Kivimaki M. Association between distance from home to tobacco outlet and smoking cessation and relapse. JAMA Intern Med. 2016;176:1512–1519. [DOI] [PubMed] [Google Scholar]
  • 49. Reitzel LR, Cromley EK, Li Y, Cao Y, Dela Mater R, Mazas CA, Cofta‐Woerpel L, Cinciripini PM, Wetter DW. The effect of tobacco outlet density and proximity on smoking cessation. Am J Public Health. 2011;101:315–320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Cao X (Jason). Exploring causal effects of neighborhood type on walking behavior using stratification on the propensity score. Environ Plan A. 2010;42:487–504. Available at: https://www.ncbi.nlm.nih.gov/nlmcatalog/101084218. [Google Scholar]
  • 51. King KE, Clarke PJ. A disadvantaged advantage in walkability: findings from socioeconomic and geographical analysis of national built environment data in the United States. Am J Epidemiol. 2015;181:17–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Chiu M, Shah BR, Maclagan LC, Rexai M‐R, Austin PC, Tu JV. Walk Score® and the prevalence of utilitarian walking and obesity among Ontario adults: a cross‐sectional study. Health Rep. 2015;26:3–10. [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data S1. Notes: ACG: Adjusted Clinical Groups; CENSUS: Ontario Canadian Census Profiles; COPD: Ontario Chronic Obstructive Pulmonary Disease Database; DAD: Discharge Abstract Database; EMRALD: Electronic Medical Record Administrative Data Linked Database; ETHNIC: Surname‐Based Ethnicity Group Database; IRCC: Immigration, Refugees and Citizenship Canada Permanent Resident Database; JHACG: Johns Hopkins Adjusted Clinical Groups; OHIP: Ontario Health Insurance Plan Billings Database; RPDB: Registered Persons Database.

Table S1. Description of Covariates Used in Multivariable Models

Table S2. Association Between Neighborhood Walkability and 10‐Year Cardiovascular Disease Risk Stratified by Current Smoking Status

Table S3. Model Results From Complete Case Analyses


Articles from Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease are provided here courtesy of Wiley

RESOURCES